Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Shennak, Mustafa Mahmoud
NCT05853835: First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641	Recruiting	1	72	US, RoW	LPX-TI641	LAPIX Therapeutics Inc.	Autoimmune Diseases, Multiple Sclerosis	08/24	11/24
Triumpharma
NCT05853835: First-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641	Recruiting	1	72	US, RoW	LPX-TI641	LAPIX Therapeutics Inc.	Autoimmune Diseases, Multiple Sclerosis	08/24	11/24